In response to the COVID-19 pandemic, governments across the United States relaxed restrictions on telemedicine, allowing more patients to receive healthcare remotely than ever before. This development brought a number of questions about how telehealth should be regulated to the fore. Is remote care as effective as in-person care? Would long-turn expansion of telemedicine reduce costs for patients and healthcare providers? Might a greater reliance on telehealth actually reduce access to care for some patients?